Evaluation of the potential complication of interstitial lung disease associated with antifibrotic drugs using data from databases reporting spontaneous adverse effects

• Autors principals: Hideki Nawa (Autor), Hirofumi Hamano (Autor), Takahiro Niimura (Autor), Koji Miyata (Autor), Kenta Yagi (Autor), Mitsuhiro Goda (Autor), Yoshito Zamami (Autor), Keisuke Ishizawa (Autor)
• Format: Llibre
• Publicat: Wiley, 2022-12-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Abstract Interstitial lung disease (ILD), as an adverse effect of certain drugs, leads to inflammation and damage in the walls of the alveoli, making it difficult for the alveoli to take up oxygen. Interstitial pneumonia with no identifiable cause is called idiopathic interstitial pneumonia (IIP), a...